Literature DB >> 18534715

Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season.

Alexander J Kallen1, Joan Brunkard, Zachary Moore, Philip Budge, Kathryn E Arnold, Gregory Fosheim, Lyn Finelli, Susan E Beekmann, Philip M Polgreen, Rachel Gorwitz, Jeffrey Hageman.   

Abstract

STUDY
OBJECTIVE: Staphylococcus aureus is a cause of community-acquired pneumonia that can follow influenza infection. In response to a number of cases reported to public health authorities in early 2007, additional case reports were solicited nationwide to better define S. aureus community-acquired pneumonia during the 2006 to 2007 influenza season.
METHODS: Cases were defined as primary community-acquired pneumonia caused by S. aureus occurring between November 1, 2006, and April 30, 2007. Case finding was conducted through an Emerging Infections Network survey and through contacts with state and local health departments.
RESULTS: Overall, 51 cases were reported from 19 states; 37 (79%) of 47 with known susceptibilities involved infection with methicillin-resistant S. aureus (MRSA). The median age of case patients was 16 years, and 44% had no known pertinent medical history. Twenty-two (47%) of 47 case patients with information about other illnesses were diagnosed with a concurrent or antecedent viral infection during their illness, and 11 of 33 (33%) who were tested had laboratory-confirmed influenza. Of the 37 patients with MRSA infection, 16 (43%) were empirically treated with antimicrobial agents recommended for MRSA community-acquired pneumonia. Twenty-four (51%) of 47 patients for whom final disposition was known died a median of 4 days after symptom onset.
CONCLUSION: S. aureus continues to cause community-acquired pneumonia, with most reported cases caused by MRSA and many occurring with or after influenza. In this series, patients were often otherwise healthy young people and mortality rates were high. Further prospective investigation is warranted to clarify infection incidence, risk factors, and preventive measures.

Entities:  

Mesh:

Year:  2008        PMID: 18534715     DOI: 10.1016/j.annemergmed.2008.04.027

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  50 in total

1.  New look at an old problem: bacterial superinfection after influenza.

Authors:  Kevan L Hartshorn
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

2.  Protection of racial/ethnic minority populations during an influenza pandemic.

Authors:  Sonja S Hutchins; Kevin Fiscella; Robert S Levine; Danielle C Ompad; Marian McDonald
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes.

Authors:  Nicolas Rouzic; Frédéric Janvier; Nicolas Libert; Etienne Javouhey; Gerard Lina; Jacques-Yves Nizou; Pierre Pasquier; Didier Stamm; Louis Brinquin; Christophe Pelletier; François Vandenesch; Daniel Floret; Jerome Etienne; Yves Gillet
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

4.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.

Authors:  Mona Doss; Piotr Ruchala; Tesfaldet Tecle; Donald Gantz; Anamika Verma; Alex Hartshorn; Erika C Crouch; Hai Luong; Ewa D Micewicz; Robert I Lehrer; Kevan L Hartshorn
Journal:  J Immunol       Date:  2012-02-15       Impact factor: 5.422

Review 6.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

7.  Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports.

Authors:  Lukas Kreienbuehl; Emmanuel Charbonney; Philippe Eggimann
Journal:  Ann Intensive Care       Date:  2011-12-22       Impact factor: 6.925

8.  Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit.

Authors:  B Sertogullarindan; B Ozbay; H Gunini; A Sunnetcioglu; A Arisoy; H M Bilgin; B Mermit Cilingir; M Duran; H Yildiz; S Ekin; Ai Baran
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

9.  Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.

Authors:  Brook E Ragle; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

10.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.